Inspections, Compliance, Enforcement, and Criminal Investigations

Supermercado Econo Inc. E 9/8/15


Department of Health and Human Services logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration
San Juan District
Compliance Branch
466 Fernández Juncos Ave.
San Juan, PR 00901-3223
Telephone: (787) 729-8500 


September 8, 2015
Hector Barreto
General Manager
Supermercados Econo, Inc. (FEI: 3011307354)
Ave Campo Rico (Esq. Baldorioty De Castro)
Carolina, Puerto Rico  00983
Dear Mr. Barreto:
On April 23, 2015, your firm offered for Import (Imported) into United States a shipment of Dasheen (Yautia Lila) under Entry 256-0335580-8.
On May 4, 2015, you were notified that the Food and Drug Administration (FDA) laboratory analysis found Trifloxystrobin and Cyprocozole, two pesticides for which tolerance limit is zero or not established, which causes the Dasheen (Yautía Lila) to be adulterated under Section 402 (a)(2)(B) of the Federal Food Drug and Cosmetic Act or “the Act” [21 U.S.C 342 (a)(2)(B)].  
On July 23, 2015, we refused the shipment of Dasheen products, by means of a Notice of FDA Action sent to your U.S. Custom Broker requesting the entire shipment to be or designating as detained. Despite this refusal, you distributed the shipment into U.S. commerce for consumption without an FDA release.  Your action constitute a violation of Title 21 of the Code of Federal Regulations (21 CFR), Section 1.90, which requires the importer to hold an imported article and not distribute it pending receipt of the results of examination of the collected sample, a “May Proceed Notice,” or a Notice of Release” from FDA.
On July 23, 2015, United States Customs Border Protection (CBP) issued a Notice to Redeliver (CBP Form 4647) requesting the redeliver of the Dasheen (Yautía Lila) shipment. Your failure to comply with this Notice is also subject to a CBP penalty action.
Failure to promptly correct this situation and prevent future premature distribution of imported products may result in future shipments being held in a CBP secured storage facility. Secured storage facilities are under the strict supervision and direction of CBP in a bonded warehouse, and you will be responsible for all costs incurred for holding your product at one of these facilities. 
It is your responsibility, as an importer, to ensure that imported products meet all the requirements of the Act and pertinent regulations. You failed to hold intact the shipment of Dasheen (Yautía Lila) causing a full premature distribution into commerce of such Dasheen, which has been found adulterated. This is a prohibited act under section 301(c) of the Act (21 U.S.C. 331(c)). You are responsible for assuring that these products you distributed are not adulterated and are otherwise in compliance with the law. Failure to do so may result in regulatory action, without further notice, such as seizure and/or injunction.
Please provide a response in writing within fifteen (15) working days of receipt of this letter outlining the specific steps you have taken to correct the violation, including an explanation of each step being taken to prevent recurrence of a premature distribution of imported goods subject to FDA examination.
Your written reply should be addressed to the Food and Drug Administration, Attention Maridalia Torres, District Director, 466 Fernandez Juncos Ave., San Juan, PR 00901. You may also contact Carlos I Medina, Compliance Officer at 787-729-8616, if there are questions regarding this Warning Letter.
Maridalia Torres
District Director
San Juan District

Page Last Updated: 09/26/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English